Thyssenkrupp Nucera Adjusts Financial Outlook for 2024/25

Thyssenkrupp Nucera has revised its financial outlook for the fiscal year 2024/25. Based on preliminary results from the first nine months of the year, the company now expects group sales to range between EUR 850 million and EUR 920 million, with EBIT adjusted to between EUR -7 million and EUR 7 million. Previously, the EBIT was estimated between EUR -30 million and EUR 5 million.

The Green Hydrogen segment forecasts sales between EUR 450 million and EUR 510 million, with an EBIT of EUR -75 million to EUR -55 million. The Chlor-Alkali segment anticipates sales from EUR 380 million to EUR 420 million, with an increased EBIT expectation between EUR 55 million and EUR 75 million.

Thyssenkrupp Nucera's Q3 sales are lower than the previous year's, with Green Hydrogen and Chlor-Alkali segments also experiencing declines in Q3 sales.